Total neoadjuvant chemotherapy combined with PD‑1 blockade and IL‑2 in MSS/pMMR locally advanced rectal cancer: short-term results of a prospective, single-arm phase II study.
Saved in:
| Title: | Total neoadjuvant chemotherapy combined with PD‑1 blockade and IL‑2 in MSS/pMMR locally advanced rectal cancer: short-term results of a prospective, single-arm phase II study. |
|---|---|
| Authors: | Tang J; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China., Wang L; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China., Yang S; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China.; Department of General Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, China., Peng W; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China., Zhang Y; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China., Zhang Y; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China., Jin K; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China., Wang X; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. wxw0213@njmu.edu.cn.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China. wxw0213@njmu.edu.cn.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China. wxw0213@njmu.edu.cn., Feng Y; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. fengyifei1982@163.com.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China. fengyifei1982@163.com., Sun Y; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. sunyueming@njmu.edu.cn.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China. sunyueming@njmu.edu.cn.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China. sunyueming@njmu.edu.cn. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 May 04; Vol. 11 (1). Date of Electronic Publication: 2026 May 04. |
| Publication Type: | Journal Article; Clinical Trial, Phase II |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42071008 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Total neoadjuvant chemotherapy combined with PD‑1 blockade and IL‑2 in MSS/pMMR locally advanced rectal cancer: short-term results of a prospective, single-arm phase II study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tang+J%22">Tang J</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Yang+S%22">Yang S</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China.; Department of General Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, China.<br /><searchLink fieldCode="AU" term="%22Peng+W%22">Peng W</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Jin+K%22">Jin K</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. wxw0213@njmu.edu.cn.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China. wxw0213@njmu.edu.cn.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China. wxw0213@njmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Feng+Y%22">Feng Y</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. fengyifei1982@163.com.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China. fengyifei1982@163.com.<br /><searchLink fieldCode="AU" term="%22Sun+Y%22">Sun Y</searchLink>; Centre of Colorectum Cancer, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. sunyueming@njmu.edu.cn.; Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, Jiangsu, China. sunyueming@njmu.edu.cn.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China. sunyueming@njmu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2026 May 04; Vol. 11 (1). <i>Date of Electronic Publication: </i>2026 May 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42071008 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41392-026-02683-8 Languages: – Code: eng Text: English Titles: – TitleFull: Total neoadjuvant chemotherapy combined with PD‑1 blockade and IL‑2 in MSS/pMMR locally advanced rectal cancer: short-term results of a prospective, single-arm phase II study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tang J – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Yang S – PersonEntity: Name: NameFull: Peng W – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Jin K – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Feng Y – PersonEntity: Name: NameFull: Sun Y IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 05 Text: 2026 May 04 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2059-3635 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Signal transduction and targeted therapy Type: main |
| ResultId | 1 |